GRANTS

296 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIH intends to fund an estimate of three to five awards, corresponding to a total of $1.5 million, for fiscal year 2018. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) (RFA-NS-18-030)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $15 million to fund 20 awards.

Due Date: July 3, 2018; November 6, 2018; July 3, 2019; November 6, 2019; July 1, 2020; November 10, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: June 19, 2018, October 17, 2018, February 20, 2019, June 19, 2019, October 17, 2019, February 19, 2020, June 17, 2020, October 20, 2020 and February 17, 2021 apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: June 19, 2018, October 17, 2018, February 20, 2019, June 19, 2019, October 17, 2019, February 19, 2020, June 17, 2020, October 20, 2020 and February 17, 2021 apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinic

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: ): June 19, 2018, October 17, 2018, February 20, 2019, June 19, 2019, October 17, 2019, February 19, 2020, June 17, 2020, October 20, 2020 and February 17, 2021 apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

ADDF-Harrington Scholar Program

Sponsor: Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Award

Award: Up to $300,000 per year for two years.

Due Date: May 25, 2018

BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: The NIH anticipates providing $10 million per year to fund an estimated 15-20 awards.

Due Date: May 15, 2018, October 29, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: The NIH anticipates providing $10 million per year to fund an estimated 15-20 awards.

Due Date: May 15, 2018, October 29, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The Teva CNS Target Identification Challenge

Sponsor: Teva Pharmaceuticals, ALS Association, HDSA Award Amount: varies

Award: The top submissions will be considered for awards ranging from $10,000 to $30,000. Up to $40,000 in cash awards may be distributed.

Due Date: April 29, 2018

Current Filters

No filters selected

Filter By